Cargando…
Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life
PURPOSE: To assess treatment toxicity and patients' survival/quality of life (QoL) after volumetric modulated arc therapy (VMAT) with simultaneous in-field boost (SIB) for cancer patients with 1 - 4 brain metastases (BM) treated with or without surgery. METHODS AND MATERIALS: Between March and...
Autores principales: | Weber, Damien C, Caparrotti, Francesca, Laouiti, Mohamed, Malek, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158112/ https://www.ncbi.nlm.nih.gov/pubmed/21714935 http://dx.doi.org/10.1186/1748-717X-6-79 |
Ejemplares similares
-
Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost
por: Steber, Cole, et al.
Publicado: (2020) -
Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer
por: Yang, Yongqiang, et al.
Publicado: (2019) -
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015) -
The patient-reported outcome measures in oropharyngeal, laryngeal and hypopharyngeal cancer patients treated with Volumetric Modulated Arc based simultaneous integrated boost radiotherapy
por: Elumalai, Thiraviyam, et al.
Publicado: (2021) -
Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy
por: Nicolini, Giorgia, et al.
Publicado: (2009)